Literature DB >> 25262992

Serum homocysteine levels, oxidative stress and cardiovascular risk in non-alcoholic steatohepatitis.

Nicoleta V Leach1, Eleonora Dronca2, Stefan C Vesa3, Dorel P Sampelean1, Elena C Craciun4, Monica Lupsor1, Dana Crisan1, Roxana Tarau5, Razvan Rusu6, Ioana Para1, Mircea Grigorescu1.   

Abstract

INTRODUCTION: Hyperhomocysteinemia is considered an independent risk factor for cardiovascular disease. Oxidative stress is one of the major pathogenic mechanisms in non-alcoholic fatty liver disease and atherosclerosis. AIM: Our study aimed to evaluate serum homocysteine levels and oxidative stress in patients with biopsy-proven non-alcoholic steatohepatitis and possible association with cardiovascular risk measured by carotid artery intima-media thickness (c-IMT). PATIENTS AND METHODS: 50 patients with non-alcoholic steatohepatitis and 30 healthy controls, age and gender matched, were recruited. Lipid profile, liver biochemical markers, serum homocysteine, vitamins B6 and B12, folic acid, glutathione (reduced and total), erythrocyte superoxide dismutase, whole blood glutathione peroxidase, malondialdehyde and carotid intima-media thickness were assayed.
RESULTS: Patients had an altered lipid profile and liver biochemical markers; carotid intima-media thickness and serum homocysteine levels were significantly higher compared to controls, but there were no differences in folate, B12 and B6 vitamins levels. Patients had significantly lower levels of glutathione peroxidase activity, total and reduced glutathione and higher levels of malondialdehyde, but unchanged superoxide dismutase activity compared to control group. Also, serum homocysteine level showed significant positive correlation with waist circumference, body mass index, free cholesterol, triglycerides, LDL-cholesterol, amino transferases and negative correlation with reduced and total glutathione, superoxide dismutase and γ-GT.
CONCLUSION: Non-alcoholic steatohepatitis is an independent cardiovascular risk factor, associated with elevated homocysteine levels, oxidative stress and c-IMT. c-IMT could be used as an indicator of early atherosclerotic changes initiated by dyslipidemia and oxidative stress, while higher level of homocysteine might be an effect of liver damage.
Copyright © 2014 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiovascular risk; Carotid artery intima-media thickness; Homocysteine; Non-alcoholic steatohepatitis; Oxidative stress

Mesh:

Substances:

Year:  2014        PMID: 25262992     DOI: 10.1016/j.ejim.2014.09.007

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  22 in total

1.  Epigenetically mediated inhibition of S-adenosylhomocysteine hydrolase and the associated dysregulation of 1-carbon metabolism in nonalcoholic steatohepatitis and hepatocellular carcinoma.

Authors:  Igor P Pogribny; Kostiantyn Dreval; Iryna Kindrat; Stepan Melnyk; Leandro Jimenez; Aline de Conti; Volodymyr Tryndyak; Marta Pogribna; Juliana Festa Ortega; S Jill James; Ivan Rusyn; Frederick A Beland
Journal:  FASEB J       Date:  2018-01-03       Impact factor: 5.191

2.  Elevated Plasma Homocysteine Level Increased the Risk of Early Renal Impairment in Acute Ischemic Stroke Patients.

Authors:  Jingjuan Chen; Guode Li; Zuohang Xu; Chengguo Zhang; Yukai Wang; Haiqun Xie; Yan Shao; Lingmei Peng; Jiancong Lu; Dahua Yuan
Journal:  Cell Mol Neurobiol       Date:  2017-03-08       Impact factor: 5.046

3.  Plasma Homocysteine Levels Predict the Risk of Acute Cerebral Infarction in Patients with Carotid Artery Lesions.

Authors:  Wei Wu; Yi Guan; Kan Xu; Xi-Jia Fu; Xiao-Feng Lei; Li-Jian Lei; Zhi-Qing Zhang; Yan Cheng; Yun-Qian Li
Journal:  Mol Neurobiol       Date:  2015-06-11       Impact factor: 5.590

Review 4.  Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV.

Authors:  Amedeo Lonardo; Stefano Ballestri; Giovanni Guaraldi; Fabio Nascimbeni; Dante Romagnoli; Stefano Zona; Giovanni Targher
Journal:  World J Gastroenterol       Date:  2016-11-28       Impact factor: 5.742

5.  Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients.

Authors:  Yanjin Hu; Jia Liu; Xuejie Dong; Yuan Xu; Song Leng; Guang Wang
Journal:  Med Sci Monit       Date:  2016-11-02

6.  Association of homocysteine level with biopsy-proven non-alcoholic fatty liver disease: a meta-analysis.

Authors:  Yining Dai; Jinzhou Zhu; Di Meng; Chaohui Yu; Youming Li
Journal:  J Clin Biochem Nutr       Date:  2015-08-29       Impact factor: 3.114

7.  Sex Difference in the Association between Serum Homocysteine Level and Non-Alcoholic Fatty Liver Disease.

Authors:  Bo-Youn Won; Kyung-Chae Park; Soo-Hyun Lee; Sung-Hwan Yun; Moon-Jong Kim; Kye-Seon Park; Young-Sang Kim; Ji-Hee Haam; Hyung-Yuk Kim; Hye-Jung Kim; Ki-Hyun Park
Journal:  Korean J Fam Med       Date:  2016-07-21

8.  Effect of Folic Acid, Betaine, Vitamin B₆, and Vitamin B12 on Homocysteine and Dimethylglycine Levels in Middle-Aged Men Drinking White Wine.

Authors:  Daniel Rajdl; Jaroslav Racek; Ladislav Trefil; Pavel Stehlik; Jana Dobra; Vaclav Babuska
Journal:  Nutrients       Date:  2016-01-12       Impact factor: 5.717

9.  Association between homocysteine and non-alcoholic fatty liver disease in Chinese adults: a cross-sectional study.

Authors:  Haijiang Dai; Weijun Wang; Xiaohong Tang; Ruifang Chen; Zhiheng Chen; Yao Lu; Hong Yuan
Journal:  Nutr J       Date:  2016-12-12       Impact factor: 3.271

10.  Intake of Nutrients, Fiber, and Sugar in Patients with Nonalcoholic Fatty Liver Disease in Comparison to Healthy Individuals.

Authors:  Hamid Zolfaghari; Gholamreza Askari; Fereydoun Siassi; Awat Feizi; Gity Sotoudeh
Journal:  Int J Prev Med       Date:  2016-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.